Angiocrine Bioscience
John Lomoro, CPA has a extensive experience in the finance and accounting industry. John is currently the Chief Financial Officer at Angiocrine Bioscience, overseeing financial strategy and operations. Prior to their current role, John has held various leadership positions in companies such as CFO Systems, LLC, Trackforce Valiant, and Kyriba Corporation. John has a Bachelor of Science in Accounting from St. Cloud State University and began their career as an Audit Manager at Ernst & Young.
Angiocrine Bioscience
Angiocrine Bioscience is a private, clinical-stage cell and gene therapy company harnessing the power of genetically modified human endothelial cells to regenerate tissues, restore function and rejuvenate patients with serious medical conditions.